Freshfields is advising Zymergen Inc. (Nasdaq: ZY), a biotechnology company that uses a combination of software, biology, chemistry and automation to develop and manufacture bio-based breakthrough products and materials, in its sale to Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a leading horizontal platform for cell programming, in an all-stock transaction valued at approximately $300 million. The transaction represents the first-ever sale of a publicly-listed public benefit corporation. Details of the transaction and its rationale can be found here.
The Freshfields team is led by M&A Partner Joseph Halloum and capital markets Partner Sarah Solum, as well as M&A Counsel Oliver Board and Associates Victor Ma, Joyce Yeo, Jenny Park and Wicy Wang; executive compensation and employee benefits Partner Lori Goodman, Counsel Sarah Ghulamhussain and Associate Lina Zhu; antitrust Partner Justin Stewart-Teitelbaum, Counsel Angela Landry and Associate Lauren Vaca; tax Partner Claude Stansbury and Senior Associate David Mitchell; IP/tech transactions Partner Mena Kaplan and Associates Marissa Yu and Mili Astesiano; data privacy and security Partner Christine Lyon, Counsel Brock Dahl and Associate Cody Goodchild; foreign investment/trade compliance Partners Aimen Mir and Nabeel Yousef and Senior Associate Amy Cattle; life sciences Partner Vinita Kailasanath and Associate Sora Park; and litigation Partners Boris Feldman, Meredith Kotler and Doru Gavril and Senior Associate Drew Liming.
Freshfields also had served as issuer’s counsel to Zymergen on its IPO on Nasdaq as a public benefit corporation.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
